Get the Stockscreener App
327.03
1.56%
-5.18
Bio Rad Laboratories Inc stock is traded at $327.03, with a volume of 124.18K.
It is down -1.56% in the last 24 hours and down -3.74% over the past month.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
See More
Previous Close:
$332.21
Open:
$330.38
24h Volume:
124.18K
Relative Volume:
0.57
Market Cap:
$7.16B
Revenue:
$2.58B
Net Income/Loss:
$-778.69M
P/E Ratio:
-11.97
EPS:
-27.33
Net Cash Flow:
$223.75M
1W Performance:
+7.30%
1M Performance:
-3.74%
6M Performance:
+46.14%
1Y Performance:
-3.17%
1-Day Range:
$326.64
$334.00
1-Week Range:
$298.35
$334.53
52-Week Range:
$211.43
$373.69
Bio Rad Laboratories Inc Stock (BIO) Company Profile
Name
Bio Rad Laboratories Inc
Sector
Industry
Phone
(510) 724-7000
Address
1000 ALFRED NOBEL DRIVE, HERCULES
Compare BIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BIO
Bio Rad Laboratories Inc
|
327.03 | 8.96B | 2.58B | -778.69M | 223.75M | -27.33 |
|
ABT
Abbott Laboratories
|
128.54 | 222.66B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
100.96 | 150.26B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
372.29 | 143.44B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
105.02 | 135.12B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
86.75 | 50.38B | 5.88B | 1.34B | 799.60M | 2.3489 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-01-24 | Upgrade | Citigroup | Neutral → Buy |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Apr-03-24 | Downgrade | Citigroup | Buy → Neutral |
| Dec-07-23 | Initiated | UBS | Buy |
| Jun-16-23 | Initiated | Wells Fargo | Overweight |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jan-28-22 | Reiterated | Citigroup | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Oct-17-18 | Initiated | Goldman | Buy |
| Sep-20-18 | Initiated | Morgan Stanley | Equal-Weight |
| Feb-16-18 | Downgrade | CL King | Buy → Neutral |
| Jul-13-17 | Initiated | Wells Fargo | Outperform |
| Jun-28-17 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-18-17 | Initiated | Deutsche Bank | Hold |
| Oct-13-16 | Initiated | CL King | Buy |
| May-06-15 | Reiterated | Jefferies | Buy |
| Dec-18-09 | Initiated | Maxim Group | Buy |
| Nov-06-09 | Initiated | Jefferies & Co | Buy |
| Jul-17-09 | Initiated | Soleil | Buy |
| Sep-26-07 | Initiated | Banc of America Sec | Buy |
| Feb-23-07 | Downgrade | Robert W. Baird | Outperform → Neutral |
View All
Bio Rad Laboratories Inc Stock (BIO) Latest News
Laboratory Proficiency Testing Market- By Type LGC Limited - openPR.com
Understanding Momentum Shifts in (BIO) - news.stocktradersdaily.com
US STD Diagnostics Market Forecast and Company Analysis 2025-2033 Featuring Abbott, F. Hoffmann-La Roche, Hologic, BD and Co, Danaher, Siemens, bioMerieux, Thermo Fisher Scientific, Qiagen, Bio-Rad - GlobeNewswire
Chromatography Accessories and Consumables Market Size, - openPR.com
Gene Transfer Technologies Market is expected to reach US$ 8.74 - openPR.com
Rare Cell Isolation Market See Incredible Growth 2025-2032 with - openPR.com
Peripheral Blood Mononuclear Cells Market Is Booming Worldwide - openPR.com
Enzyme Immunoassay Market Is Booming Worldwide 2025-2032 | Bio-Rad, Roche, Siemens Healthineers, and Abbott - openPR.com
Hemoglobinopathies Market- By Type Abbott Diagnostics, Bio-Rad Laboratories Inc., Danaher Corporation - openPR.com
Hematology Market- By Type Abbott, Agilent, Bio-Rad, Danaher Dolomite - openPR.com
Functional Genomics Market Set to Boom: Strategic Insights - openPR.com
Lab on Chip Market 2025- 2032 Overview: Share, Size, Value, - openPR.com
Bio-Rad extends partnership with Gencurix through strategic agreement for Droplet Digital™ PCR IVD oncology kits in Europe - MSN
EBITDA per share of Bio-Rad Laboratories, Inc. Class B – FWB:BUW - TradingView
Free cash flow per share of Bio-Rad Laboratories, Inc. Class B – FWB:BUW - TradingView
What analysts say about Bio Rad Laboratories Inc stockPrice Action Trading & Free Tap Rapid Wealth - earlytimes.in
How Bio Rad Laboratories Inc. (BUW) stock correlates with oil marketsJuly 2025 Update & High Yield Stock Recommendations - newser.com
Why Bio Rad Laboratories Inc. (BUWA) stock is a must watch ticker2025 Price Action Summary & Weekly High Return Forecasts - newser.com
Is Bio Rad Laboratories Inc. Class B stock expanding market penetration2025 Valuation Update & Accurate Entry and Exit Point Alerts - newser.com
How Bio Rad Laboratories Inc. (BUWA) stock stacks up against competitorsPortfolio Return Report & Fast Momentum Stock Entry Tips - newser.com
Is Bio Rad Laboratories Inc. Class stock at risk of policy regulationForecast Cut & Consistent Profit Trading Strategies - newser.com
Why Bio Rad Laboratories Inc. Class stock stays on top picksJuly 2025 Analyst Calls & Precise Buy Zone Tips - newser.com
Is Bio Rad Laboratories Inc. (BUW) stock cheap vs fundamentals2025 Institutional Moves & Accurate Trade Setup Notifications - newser.com
Is Bio Rad Laboratories Inc. (BUW) stock a buy before new product rolloutMarket Performance Summary & Low Risk Investment Opportunities - newser.com
Published on: 2025-11-21 01:52:15 - newser.com
Bacterial Cell Culture Market Size, Outlook 2032 by Key - openPR.com
Will Bio Rad Laboratories Inc. Class stock rise with strong economyPortfolio Performance Report & Daily Profit Focused Stock Screening - newser.com
What is the fair value estimate for Bio Rad Laboratories Inc. Class B stock in 2025Buy Signal & Real-Time Volume Surge Alerts - newser.com
What RSI levels show for Bio Rad Laboratories Inc. Class B stockJuly 2025 Intraday Action & AI Enhanced Execution Alerts - newser.com
What valuation ratios show for Bio Rad Laboratories Inc. (BUWA) stockMarket Movers & Growth Focused Stock Pick Reports - newser.com
Can Bio Rad Laboratories Inc. (BUWA) stock ride next bull market cycle2025 Geopolitical Influence & Detailed Earnings Play Alerts - newser.com
How Bio Rad Laboratories Inc. (BUWA) stock performs in volatility spikesWeekly Stock Report & Momentum Based Trading Ideas - newser.com
Is Bio Rad Laboratories Inc. (BUWA) stock positioned for secular growthMarket Growth Summary & Free High Accuracy Swing Entry Alerts - newser.com
How Bio Rad Laboratories Inc. Class B stock trades pre earnings2025 Market Sentiment & Free AI Powered Buy and Sell Recommendations - newser.com
Published on: 2025-11-19 23:54:32 - newser.com
Published on: 2025-11-19 22:26:31 - newser.com
Will Bio Rad Laboratories Inc. (BUW) stock deliver compounding returnsDollar Strength & AI Enhanced Trading Alerts - newser.com
Bio Rad Laboratories Inc. stock trend forecastM&A Rumor & AI Enhanced Market Trend Forecasts - newser.com
Will Bio Rad Laboratories Inc. (BUW) stock see valuation expansion2025 Earnings Impact & Precise Swing Trade Alerts - newser.com
Is Bio Rad Laboratories Inc. (BUWA) stock a buy during volatile markets2025 Trading Recap & Precise Trade Entry Recommendations - newser.com
Is Bio Rad Laboratories Inc. (BUW) stock a good hedge against inflation2025 Winners & Losers & High Accuracy Trade Alerts - newser.com
Exit strategy if you’re trapped in Bio Rad Laboratories Inc.2025 Market WrapUp & Stepwise Trade Signal Guides - newser.com
Bio Rad Laboratories Inc Stock (BIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.62%
1.36%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):